{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:38:15Z","timestamp":1789043895798,"version":"build-2803163510"},"reference-count":96,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2024,9,1]]},"DOI":"10.5551\/jat.rv22020","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T22:14:20Z","timestamp":1719440060000},"page":"1239-1248","source":"Crossref","is-referenced-by-count":12,"title":["Bridging the Gap Between the Bench and Bedside: Clinical Applications of High-density Lipoprotein Function"],"prefix":"10.5551","volume":"31","author":[{"given":"Yasuhiro","family":"Endo","sequence":"first","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"},{"name":"Division of Environmental Medicine, National Defense Medical College Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Ikewaki","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Barr DP, Russ EM, Eder HA: Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am J Med, 1951; 11: 480-493","DOI":"10.1016\/0002-9343(51)90183-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Wilson PW, Abbott RD, Castelli WP: High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis, 1988; 8: 737-741","DOI":"10.1161\/01.ATV.8.6.737"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Assmann G, Schulte H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular M\u00fcnster study. Am J Cardiol, 1992; 70: 733-737","DOI":"10.1016\/0002-9149(92)90550-I"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Madsen CM, Varbo A, Nordestgaard BG: Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J, 2017; 38: 2478-2486","DOI":"10.1093\/eurheartj\/ehx163"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hirata A, Sugiyama D, Watanabe M, Tamakoshi A, Iso H, Kotani K, Kiyama M, Yamada M, Ishikawa S, Murakami Y, Miura K, Ueshima H, Okamura T: Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study. J Clin Lipidol, 2018; 12: 674-684.e675","DOI":"10.1016\/j.jacl.2018.01.014"},{"key":"6","unstructured":"6) Zanoni P, Khetarpal SA, Larach DB, Hancock-Cerutti WF, Millar JS, Cuchel M, DerOhannessian S, Kontush A, Surendran P, Saleheen D, Trompet S, Jukema JW, De Craen A, Deloukas P, Sattar N, Ford I, Packard C, Majumder A, Alam DS, Di Angelantonio E, Abecasis G, Chowdhury R, Erdmann J, Nordestgaard BG, Nielsen SF, Tybj\u00e6rg-Hansen A, Schmidt RF, Kuulasmaa K, Liu DJ, Perola M, Blankenberg S, Salomaa V, M\u00e4nnist\u00f6 S, Amouyel P, Arveiler D, Ferrieres J, M\u00fcller-Nurasyid M, Ferrario M, Kee F, Willer CJ, Samani N, Schunkert H, Butterworth AS, Howson JM, Peloso GM, Stitziel NO, Danesh J, Kathiresan S, Rader DJ: Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science, 2016; 351: 1166-1171"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Taheri H, Filion KB, Windle SB, Reynier P, Eisenberg MJ: Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cardiology, 2020; 145: 236-250","DOI":"10.1159\/000505365"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W: Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med, 2011; 365: 2255-2267","DOI":"10.1056\/NEJMoa1107579"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Zanotti I, Poti F, Cuchel M: HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies. Biochim Biophys Acta Mol Cell Biol Lipids, 2022; 1867: 159065","DOI":"10.1016\/j.bbalip.2021.159065"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Brites F, Martin M, Guillas I, Kontush A: Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit. BBA Clin, 2017; 8: 66-77","DOI":"10.1016\/j.bbacli.2017.07.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fotakis P, Kothari V, Thomas DG, Westerterp M, Molusky MM, Altin E, Abramowicz S, Wang N, He Y, Heinecke JW, Bornfeldt KE, Tall AR: Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques. Arterioscler Thromb Vasc Biol, 2019; 39: e253-e272","DOI":"10.1161\/ATVBAHA.119.313253"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ruiz M, Okada H, Dahlback B: HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium. Lipids Health Dis, 2017; 16: 36","DOI":"10.1186\/s12944-017-0429-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mineo C, Yuhanna IS, Quon MJ, Shaul PW: High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem, 2003; 278: 9142-9149","DOI":"10.1074\/jbc.M211394200"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) van der Stoep M, Korporaal SJ, Van Eck M: High-density lipoprotein as a modulator of platelet and coagulation responses. Cardiovasc Res, 2014; 103: 362-371","DOI":"10.1093\/cvr\/cvu137"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, Lopez-Sendon J, Ostadal P, Koenig W, Angoulvant D, Gregoire JC, Lavoie MA, Dube MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, L\u2019Allier PL, Guertin MC, Roubille F: Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med, 2019; 381: 2497-2505","DOI":"10.1056\/NEJMoa1912388"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ: Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med, 2017; 377: 1119-1131","DOI":"10.1056\/NEJMoa1707914"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Jia C, Anderson JLC, Gruppen EG, Lei Y, Bakker SJL, Dullaart RPF, Tietge UJF: High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events. Circulation, 2021; 143: 1935-1945","DOI":"10.1161\/CIRCULATIONAHA.120.050808"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Glomset JA: The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res, 1968; 9: 155-167","DOI":"10.1016\/S0022-2275(20)43114-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Oram JF, Albers JJ, Cheung MC, Bierman EL: The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J Biol Chem, 1981; 256: 8348-8356","DOI":"10.1016\/S0021-9258(19)68850-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Roheim PS: Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport. Am J Cardiol, 1986; 57: 3c-10c","DOI":"10.1016\/0002-9149(86)91020-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhang Y, Zanotti I, Reilly MP, Glick JM, Rothblat GH, Rader DJ: Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation, 2003; 108: 661-663","DOI":"10.1161\/01.CIR.0000086981.09834.E0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J, Tippin TK, Wang X, Lusis AJ, Hsueh WA, Law RE, Collins JL, Willson TM, Tontonoz P: Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A, 2002; 99: 7604-7609","DOI":"10.1073\/pnas.112059299"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, Moore KJ: Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest, 2011; 121: 2921-2931","DOI":"10.1172\/JCI57275"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Xu Y, Li F, Zalzala M, Xu J, Gonzalez FJ, Adorini L, Lee YK, Yin L, Zhang Y: Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology, 2016; 64: 1072-1085","DOI":"10.1002\/hep.28712"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Mueller PA, Zhu L, Tavori H, Huynh K, Giunzioni I, Stafford JM, Linton MF, Fazio S: Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages. Circulation, 2018; 138: 1850-1863","DOI":"10.1161\/CIRCULATIONAHA.117.031702"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Uto-Kondo H, Ayaori M, Sotherden GM, Nakaya K, Sasaki M, Yogo M, Komatsu T, Takiguchi S, Yakushiji E, Ogura M, Nishida T, Endo Y, Ikewaki K: Ezetimibe enhances macrophage reverse cholesterol transport in hamsters: contribution of hepato-biliary pathway. Biochim Biophys Acta, 2014; 1841: 1247-1255","DOI":"10.1016\/j.bbalip.2014.05.009"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yakushiji E, Ayaori M, Nishida T, Shiotani K, Takiguchi S, Nakaya K, Uto-Kondo H, Ogura M, Sasaki M, Yogo M, Komatsu T, Lu R, Yokoyama S, Ikewaki K: Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice. Arterioscler Thromb Vasc Biol, 2016; 36: 591-597","DOI":"10.1161\/ATVBAHA.115.306376"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Cuchel M, Raper AC, Conlon DM, Pryma DA, Freifelder RH, Poria R, Cromley D, Li X, Dunbar RL, French B, Qu L, Farver W, Su CC, Lund-Katz S, Baer A, Ruotolo G, Akerblad P, Ryan CS, Xiao L, Kirchgessner TG, Millar JS, Billheimer JT, Rader DJ: A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans. J Lipid Res, 2017; 58: 752-762","DOI":"10.1194\/jlr.M075226"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ouimet M, Barrett TJ, Fisher EA: HDL and Reverse Cholesterol Transport. Circ Res, 2019; 124: 1505-1518","DOI":"10.1161\/CIRCRESAHA.119.312617"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH: The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol, 2010; 30: 796-801","DOI":"10.1161\/ATVBAHA.109.199158"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, Shaul PW: HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med, 2014; 371: 2383-2393","DOI":"10.1056\/NEJMoa1409065"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ishikawa T, Ayaori M, Uto-Kondo H, Nakajima T, Mutoh M, Ikewaki K: High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease. Atherosclerosis, 2015; 242: 318-322","DOI":"10.1016\/j.atherosclerosis.2015.06.028"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Ogura M, Hori M, Harada-Shiba M: Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia. Arterioscler Thromb Vasc Biol, 2016; 36: 181-188","DOI":"10.1161\/ATVBAHA.115.306665"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Shimizu T, Miyazaki O, Iwamoto T, Usui T, Sato R, Hiraishi C, Yoshida H: A new method for measuring cholesterol efflux capacity uses stable isotope-labeled, not radioactive-labeled, cholesterol. J Lipid Res, 2019; 60: 1959-1967","DOI":"10.1194\/jlr.D086884"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Oshita T, Toh R, Nagano Y, Kuroda K, Nagasawa Y, Harada A, Murakami K, Kiriyama M, Yoshikawa K, Miwa K, Kubo T, Iino T, Nagao M, Irino Y, Hara T, Shinohara M, Otake H, Shinke T, Nakajima K, Ishida T, Hirata KI: Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: An optical coherence tomography-based observational study. Clin Chim Acta, 2020; 503: 136-144","DOI":"10.1016\/j.cca.2020.01.001"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Fujimoto D, Otake H, Kawamori H, Toba T, Nagao M, Nakano S, Tanimura K, Takahashi Y, Fukuyama Y, Kakizaki S, Nakamura K, Harada A, Murakami K, Iino T, Toh R, Hirata KI: Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary intervention. Atherosclerosis, 2022; 345: 44-50","DOI":"10.1016\/j.atherosclerosis.2022.01.014"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Sato M, Neufeld EB, Playford MP, Lei Y, Sorokin AV, Aponte AM, Freeman LA, Gordon SM, Dey AK, Jeiran K, Hamasaki M, Sampson ML, Shamburek RD, Tang J, Chen MY, Kotani K, Anderson JL, Dullaart RP, Mehta NN, Tietge UJ, Remaley AT: Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease. J Clin Invest, 2023; 133","DOI":"10.1172\/JCI165370"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Song Y, Liu J, Zhao K, Gao L, Zhao J: Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases. Cell Metab, 2021; 33: 1911-1925","DOI":"10.1016\/j.cmet.2021.09.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Schmidt AM: Diabetes Mellitus and Cardiovascular Disease. Arterioscler Thromb Vasc Biol, 2019; 39: 558-568","DOI":"10.1161\/ATVBAHA.119.310961"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Cavallero E, Brites F, Delfly B, Nicola\u00efew N, Decossin C, De Geitere C, Fruchart JC, Wikinski R, Jacotot B, Castro G: Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. Arterioscler Thromb Vasc Biol, 1995; 15: 2130-2135","DOI":"10.1161\/01.ATV.15.12.2130"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) He Y, Ronsein GE, Tang C, Jarvik GP, Davidson WS, Kothari V, Song HD, Segrest JP, Bornfeldt KE, Heinecke JW: Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles. Circ Res, 2020; 127: 1198-1210","DOI":"10.1161\/CIRCRESAHA.120.317178"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Yamamoto S, Yancey PG, Ikizler TA, Jerome WG, Kaseda R, Cox B, Bian A, Shintani A, Fogo AB, Linton MF, Fazio S, Kon V: Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol, 2012; 60: 2372-2379","DOI":"10.1016\/j.jacc.2012.09.013"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Holzer M, Schilcher G, Curcic S, Trieb M, Ljubojevic S, Stojakovic T, Scharnagl H, Kopecky CM, Rosenkranz AR, Heinemann A, Marsche G: Dialysis Modalities and HDL Composition and Function. J Am Soc Nephrol, 2015; 26: 2267-2276","DOI":"10.1681\/ASN.2014030309"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Lefterov I, Fitz NF, Cronican AA, Fogg A, Lefterov P, Kodali R, Wetzel R, Koldamova R: Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP\/PS1DeltaE9 mice. J Biol Chem, 2010; 285: 36945-36957","DOI":"10.1074\/jbc.M110.127738"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Lewis TL, Cao D, Lu H, Mans RA, Su YR, Jungbauer L, Linton MF, Fazio S, LaDu MJ, Li L: Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease. J Biol Chem, 2010; 285: 36958-36968","DOI":"10.1074\/jbc.M110.127829"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Ko YA, Billheimer JT, Lyssenko NN, Kueider-Paisley A, Wolk DA, Arnold SE, Leung YY, Shaw LM, Trojanowski JQ, Kaddurah-Daouk RF, Kling MA, Rader DJ: ApoJ\/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer\u2019s disease. Alzheimers Res Ther, 2022; 14: 194","DOI":"10.1186\/s13195-022-01119-z"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Westerterp M, Fotakis P, Ouimet M, Bochem AE, Zhang H, Molusky MM, Wang W, Abramowicz S, la Bastide-van Gemert S, Wang N, Welch CL, Reilly MP, Stroes ES, Moore KJ, Tall AR: Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis. Circulation, 2018; 138: 898-912","DOI":"10.1161\/CIRCULATIONAHA.117.032636"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Gruaz L, Delucinge-Vivier C, Descombes P, Dayer JM, Burger D: Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes. PLoS One, 2010; 5: e9418","DOI":"10.1371\/journal.pone.0009418"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, Remaley AT, Sviridov D, Chin-Dusting J: High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol, 2008; 28: 2071-2077","DOI":"10.1161\/ATVBAHA.108.168690"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Sorokin AV, Kotani K, Elnabawi YA, Dey AK, Sajja AP, Yamada S, Ueda M, Harrington CL, Baumer Y, Rodante JA, Gelfand JM, Chen MY, Joshi AA, Playford MP, Remaley AT, Mehta NN: Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis. Circ Res, 2018; 123: 1244-1254","DOI":"10.1161\/CIRCRESAHA.118.313608"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Adorni MP, Zimetti F, Budoff MJ, Ronda N: ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis. J Autoimmun, 2023; 136: 103029","DOI":"10.1016\/j.jaut.2023.103029"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Mackness MI, Arrol S, Durrington PN: Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett, 1991; 286: 152-154","DOI":"10.1016\/0014-5793(91)80962-3"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A: Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler Thromb Vasc Biol, 2009; 29: 870-876","DOI":"10.1161\/ATVBAHA.109.186031"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Davignon J, Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation, 2004; 109: Iii27-32","DOI":"10.1161\/01.CIR.0000131515.03336.f8"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL: In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A, 1993; 90: 12040-12044","DOI":"10.1073\/pnas.90.24.12040"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Guo L, Ai J, Zheng Z, Howatt DA, Daugherty A, Huang B, Li XA: High density lipoprotein protects against polymicrobe-induced sepsis in mice. J Biol Chem, 2013; 288: 17947-17953","DOI":"10.1074\/jbc.M112.442699"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Chousterman BG, Swirski FK, Weber GF: Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol, 2017; 39: 517-528","DOI":"10.1007\/s00281-017-0639-8"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Davidson WS, Shah AS, Sexmith H, Gordon SM: The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function. Biochim Biophys Acta Mol Cell Biol Lipids, 2022; 1867: 159072","DOI":"10.1016\/j.bbalip.2021.159072"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW: Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest, 2007; 117: 746-756","DOI":"10.1172\/JCI26206"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Riwanto M, Rohrer L, Roschitzki B, Besler C, Mocharla P, Mueller M, Perisa D, Heinrich K, Altwegg L, von Eckardstein A, L\u00fcscher TF, Landmesser U: Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation, 2013; 127: 891-904","DOI":"10.1161\/CIRCULATIONAHA.112.108753"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Oberbach A, Adams V, Schlichting N, Heinrich M, Kullnick Y, Lehmann S, Lehmann S, Feder S, Correia JC, Mohr FW, V\u00f6lker U, Jehmlich N: Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteins. Clin Chim Acta, 2016; 453: 114-122","DOI":"10.1016\/j.cca.2015.12.005"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Weichhart T, Kopecky C, Kubicek M, Haidinger M, D\u00f6ller D, Katholnig K, Suarna C, Eller P, T\u00f6lle M, Gerner C, Zlabinger GJ, van der Giet M, H\u00f6rl WH, Stocker R, S\u00e4emann MD: Serum amyloid A in uremic HDL promotes inflammation. J Am Soc Nephrol, 2012; 23: 934-947","DOI":"10.1681\/ASN.2011070668"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Shao B, Mathew AV, Thornock C, Pennathur S, Michigan Kidney Translational Core CIG: Altered HDL proteome predicts incident CVD in chronic kidney disease patients. J Lipid Res, 2021; 62: 100135","DOI":"10.1016\/j.jlr.2021.100135"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Begue F, Tanaka S, Mouktadi Z, Rondeau P, Veeren B, Diotel N, Tran-Dinh A, Robert T, V\u00e9lia E, Mavingui P, Lagrange-X\u00e9lot M, Montravers P, Couret D, Meilhac O: Altered high-density lipoprotein composition and functions during severe COVID-19. Sci Rep, 2021; 11: 2291","DOI":"10.1038\/s41598-021-81638-1"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Vaisar T, Tang C, Babenko I, Hutchins P, Wimberger J, Suffredini AF, Heinecke JW: Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity. J Lipid Res, 2015; 56: 1519-1530","DOI":"10.1194\/jlr.M059089"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Plubell DL, Fenton AM, Rosario S, Bergstrom P, Wilmarth PA, Clark WM, Zakai NA, Quinn JF, Minnier J, Alkayed NJ, Fazio S, Pamir N: High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke. Circ Res, 2020; 127: 1274-1287","DOI":"10.1161\/CIRCRESAHA.120.316526"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Kontush A, Lhomme M, Chapman MJ: Unraveling the complexities of the HDL lipidome. J Lipid Res, 2013; 54: 2950-2963","DOI":"10.1194\/jlr.R036095"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Yancey PG, de la Llera-Moya M, Swarnakar S, Monzo P, Klein SM, Connelly MA, Johnson WJ, Williams DL, Rothblat GH: High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem, 2000; 275: 36596-36604","DOI":"10.1074\/jbc.M006924200"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Perrin-Cocon L, Diaz O, Carreras M, Dollet S, Guironnet-Paquet A, Andr\u00e9 P, Lotteau V: High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation. Immunobiology, 2012; 217: 91-99","DOI":"10.1016\/j.imbio.2011.07.030"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Kwon YG, Min JK, Kim KM, Lee DJ, Billiar TR, Kim YM: Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem, 2001; 276: 10627-10633","DOI":"10.1074\/jbc.M011449200"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Galvani S, Sanson M, Blaho VA, Swendeman SL, Obinata H, Conger H, Dahlb\u00e4ck B, Kono M, Proia RL, Smith JD, Hla T: HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal, 2015; 8: ra79","DOI":"10.1126\/scisignal.aaa2581"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Cardner M, Yalcinkaya M, Goetze S, Luca E, Balaz M, Hunjadi M, Hartung J, Shemet A, Kr\u00e4nkel N, Radosavljevic S, Keel M, Othman A, Karsai G, Hornemann T, Claassen M, Liebisch G, Carreira E, Ritsch A, Landmesser U, Kr\u00fctzfeldt J, Wolfrum C, Wollscheid B, Beerenwinkel N, Rohrer L, von Eckardstein A: Structure-function relationships of HDL in diabetes and coronary heart disease. JCI Insight, 2020; 5","DOI":"10.1172\/jci.insight.131491"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT: MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol, 2011; 13: 423-433","DOI":"10.1038\/ncb2210"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Tabet F, Vickers KC, Cuesta Torres LF, Wiese CB, Shoucri BM, Lambert G, Catherinet C, Prado-Lourenco L, Levin MG, Thacker S, Sethupathy P, Barter PJ, Remaley AT, Rye KA: HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun, 2014; 5: 3292","DOI":"10.1038\/ncomms4292"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Ridker PM: C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol, 2007; 49: 2129-2138","DOI":"10.1016\/j.jacc.2007.02.052"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Rohatgi A, Westerterp M, von Eckardstein A, Remaley A, Rye KA: HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research. Circulation, 2021; 143: 2293-2309","DOI":"10.1161\/CIRCULATIONAHA.120.044221"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Yvan-Charvet L, Welch C, Pagler TA, Ranalletta M, Lamkanfi M, Han S, Ishibashi M, Li R, Wang N, Tall AR: Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation, 2008; 118: 1837-1847","DOI":"10.1161\/CIRCULATIONAHA.108.793869"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Smoak KA, Aloor JJ, Madenspacher J, Merrick BA, Collins JB, Zhu X, Cavigiolio G, Oda MN, Parks JS, Fessler MB: Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab, 2010; 11: 493-502","DOI":"10.1016\/j.cmet.2010.04.006"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Suzuki M, Pritchard DK, Becker L, Hoofnagle AN, Tanimura N, Bammler TK, Beyer RP, Bumgarner R, Vaisar T, de Beer MC, de Beer FC, Miyake K, Oram JF, Heinecke JW: High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation, 2010; 122: 1919-1927","DOI":"10.1161\/CIRCULATIONAHA.110.961193"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) De Nardo D, Labzin LI, Kono H, Seki R, Schmidt SV, Beyer M, Xu D, Zimmer S, Lahrmann C, Schildberg FA, Vogelhuber J, Kraut M, Ulas T, Kerksiek A, Krebs W, Bode N, Grebe A, Fitzgerald ML, Hernandez NJ, Williams BR, Knolle P, Kneilling M, R\u00f6cken M, L\u00fctjohann D, Wright SD, Schultze JL, Latz E: High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol, 2014; 15: 152-160","DOI":"10.1038\/ni.2784"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, Sviridov D, Chin-Dusting JP: Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol, 2011; 31: 1333-1341","DOI":"10.1161\/ATVBAHA.111.226258"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Wang SH, Yuan SG, Peng DQ, Zhao SP: HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells. Atherosclerosis, 2012; 225: 105-114","DOI":"10.1016\/j.atherosclerosis.2012.07.029"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, Demosky SJ, Jr., Remaley AT: High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology, 2016; 149: 306-319","DOI":"10.1111\/imm.12638"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S, Welch CL, Wang N, Randolph GJ, Snoeck HW, Tall AR: ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science, 2010; 328: 1689-1693","DOI":"10.1126\/science.1189731"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Bazioti V, La Rose AM, Maassen S, Bianchi F, de Boer R, Halmos B, Dabral D, Guilbaud E, Flohr-Svendsen A, Groenen AG, Marmolejo-Garza A, Koster MH, Kloosterhuis NJ, Havinga R, Pranger AT, Langelaar-Makkinje M, de Bruin A, van de Sluis B, Kohan AB, Yvan-Charvet L, van den Bogaart G, Westerterp M: T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice. Nat Commun, 2022; 13: 3799","DOI":"10.1038\/s41467-022-31135-4"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) van der Vorst EPC, Theodorou K, Wu Y, Hoeksema MA, Goossens P, Bursill CA, Aliyev T, Huitema LFA, Tas SW, Wolfs IMJ, Kuijpers MJE, Gijbels MJ, Schalkwijk CG, Koonen DPY, Abdollahi-Roodsaz S, McDaniels K, Wang CC, Leitges M, Lawrence T, Plat J, Van Eck M, Rye KA, Touqui L, de Winther MPJ, Biessen EAL, Donners M: High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-\u03baB\/STAT1-IRF1 Signaling. Cell Metab, 2017; 25: 197-207","DOI":"10.1016\/j.cmet.2016.10.013"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED, Amadori L, Khan NS, Wong CK, Shamailova R, Hill CA, Wang Z, Remark R, Li JR, Pina C, Faries C, Awad AJ, Moss N, Bjorkegren JLM, Kim-Schulze S, Gnjatic S, Ma\u2019ayan A, Mocco J, Faries P, Merad M, Giannarelli C: Single-cell immune landscape of human atherosclerotic plaques. Nat Med, 2019; 25: 1576-1588","DOI":"10.1038\/s41591-019-0590-4"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Kluck GEG, Qian AS, Sakarya EH, Quach H, Deng YD, Trigatti BL: Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages. Arterioscler Thromb Vasc Biol, 2023; 43: 45-63","DOI":"10.1161\/ATVBAHA.122.318062"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Uehara Y, Ando S, Yahiro E, Oniki K, Ayaori M, Abe S, Kawachi E, Zhang B, Shioi S, Tanigawa H, Imaizumi S, Miura S, Saku K: FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice. J Am Heart Assoc, 2013; 2: e000048","DOI":"10.1161\/JAHA.113.000048"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R: Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. Jama, 2003; 290: 2292-2300","DOI":"10.1001\/jama.290.17.2292"},{"key":"91","unstructured":"91) Tardif JC, Ballantyne CM, Barter P, Dasseux JL, Fayad ZA, Guertin MC, Kastelein JJ, Keyserling C, Klepp H, Koenig W, L\u2019Allier PL, Lesp\u00e9rance J, L\u00fcscher TF, Paolini JF, Tawakol A, Waters DD: Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J, 2014; 35: 3277-3286"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92) Gibson CM, Kastelein JJP, Phillips AT, Aylward PE, Yee MK, Tendera M, Nicholls SJ, Pocock S, Goodman SG, Alexander JH, Lincoff AM, Bode C, Duffy D, Heise M, Berman G, Mears SJ, Tricoci P, Deckelbaum LI, Steg PG, Ridker P, Mehran R: Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. Am Heart J, 2021; 231: 121-127","DOI":"10.1016\/j.ahj.2020.10.052"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93) Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, Lincoff AM, Heise M, Tricoci P, Deckelbaum LI, Mears SJ, Nicolau JC, Lopes RD, Merkely B, Lewis BS, Cornel JH, Trebacz J, Parkhomenko A, Libby P, Sacks FM, Povsic TJ, Bonaca M, Goodman SG, Bhatt DL, Tendera M, Steg PG, Ridker PM, Aylward P, Kastelein JJP, Bode C, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA: Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction. N Engl J Med, 2024","DOI":"10.1056\/NEJMoa2400969"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94) Wang Y, Calvert AE, Cardenas H, Rink JS, Nahotko D, Qiang W, Ndukwe CE, Chen F, Keathley R, Zhang Y, Cheng JX, Thaxton CS, Matei D: Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Adv Sci (Weinh), 2024; 11: e2305212","DOI":"10.1002\/advs.202305212"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95) Gong X, Zheng C, Cai Y, Zhang W, Zhu B, Rong R, Kong Y, Zhang Y, Wang J, Li Y, Zhang P: Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer. J Control Release, 2024; 367: 637-648","DOI":"10.1016\/j.jconrel.2024.01.064"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96) Guo L, Morin EE, Yu M, Mei L, Fawaz MV, Wang Q, Yuan Y, Zhan CG, Standiford TJ, Schwendeman A, Li XA: Replenishing HDL with synthetic HDL has multiple protective effects against sepsis in mice. Sci Signal, 2022; 15: eabl9322","DOI":"10.1126\/scisignal.abl9322"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/9\/31_RV22020\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T04:32:14Z","timestamp":1725683534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/9\/31_RV22020\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22020","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]},"article-number":"RV22020"}}